Curiously, why are both pharma and dpharma so slow in informing who are their vax partners. I bet if they do so, it ll help their share price go higher
• DPHARMA – which is involved in the pharmaceutical sector – is poised to benefit from the impending rollout of Malaysia’s Covid-19 vaccination program after the government has picked the company to undertake the fill-and-finish processes for the supply of Covid-19 vaccines in the country.
• Meanwhile, the government intends to finalise the national vaccination plan (scheduled to start in February) this Thursday, which would map out a comprehensive plan on the implementation mechanism including the transportation and storage of the vaccines.
• The Group – which has delivered rising annual profits for the past three years with an increase from RM27m in FY16 to RM55m in FY19 – posted net earnings of RM42.4m (-2% YoY) in the nine-month period ended September 2020.
• Going forward, consensus is projecting DPHARMA to register net profit of RM70m in FY December 2021 and RM80m in FY December 2022, translating to forward PERs of 32.1x this year and 28.1x next year.
• On the chart, the ongoing share price correction – which has fallen 27% from a high of RM4.38 in November last year to close at RM3.18 yesterday – offers an opportunity for investors to accumulate DPHARMA shares on weakness.
• Technically speaking, the stock’s uptrend (started from a trough of RM1.61 in mid-July last year) remains intact with the 50% Fibonacci retracement line providing immediate downside support.
• On the back of an anticipated share price reversal from the oversold RSI territory, the stock could rebound to our resistance thresholds of RM3.62 (R1; 14% upside potential) and RM3.90 (R2; 23% upside potential).
• We have pegged our stop loss price at RM2.85 (or 10% downside risk).
"Earlier, Khairy also said that the Covid-19 Vaccine Supply Access Guarantee Committee will also discuss the decision to provide free Covid-19 vaccination to foreign workers, expatriates and permanent residents in the country". Malaysian are getting free vaccine and it's possible foreign workers, expatriates and PR also may get free vaccine. Dpharma can make ton's of money by distributing and storing meh ? I think the message is clear, sell before u lose your pant's
From Nov epf own 7.6% of duopharma share, until today they reach 8.34%...epf macam like to burn u guys epf contribution la...if like this maybe 20 years later ur epf money worth 0 la, cause all stock they buy rugi ma, they dunno invest la haha
Please be reminded to do your own due diligence before investing. Don't listen to others. This is also not a speculative counter. It's fundamentally business orientated with profitable earnings. Guess, Pharma is still making losses.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
BennyWhittman
1,215 posts
Posted by BennyWhittman > 2021-01-04 20:52 |
Post removed.Why?